Cargando…
Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
Vascular smooth muscle cell (VSMC) proliferation is a hallmark of neointimal hyperplasia (NIH) in atherosclerosis and restenosis post-balloon angioplasty and stent insertion. Although numerous cytotoxic and cytostatic therapeutics have been developed to reduce NIH, it is improbable that a multifacto...
Autores principales: | Ko, Dai Sik, Kang, Junho, Heo, Hye Jin, Kim, Eun Kyoung, Kim, Kihun, Kang, Jin Mo, Jung, YunJae, Baek, Seung Eun, Kim, Yun Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379418/ https://www.ncbi.nlm.nih.gov/pubmed/35982907 http://dx.doi.org/10.7150/ijbs.75577 |
Ejemplares similares
-
Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014) -
PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury
por: Yang, Han-Mo, et al.
Publicado: (2013) -
Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?
por: Tian, Ding-Yuan, et al.
Publicado: (2017) -
Activation of Protein Kinase G (PKG) Reduces Neointimal Hyperplasia, Inhibits Platelet Aggregation, and Facilitates Re-endothelialization
por: Kim, Ju-Young, et al.
Publicado: (2016) -
FRZB as a key molecule in abdominal aortic aneurysm progression affecting vascular integrity
por: Oh, Chang-Kyu, et al.
Publicado: (2021)